Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

[1]  R. Crystal,et al.  Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis. , 1994, Human gene therapy.

[2]  R. Crystal,et al.  Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. , 1994, Human gene therapy.

[3]  J. Olsen,et al.  Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North Carolina , 1994 .

[4]  R. Crystal,et al.  Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation. , 1994, American journal of respiratory cell and molecular biology.

[5]  James M. Wilson,et al.  Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia , 1994, Nature Genetics.

[6]  R. Crystal,et al.  Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA. , 1994, Human gene therapy.

[7]  J. Wilson,et al.  Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. , 1993, Human gene therapy.

[8]  J. Wilson,et al.  Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. , 1993, Human gene therapy.

[9]  B. Trapnell,et al.  Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice , 1993, Nature Genetics.

[10]  S. Suter,et al.  Regulation of cytokine secretion by cystic fibrosis airway epithelial cells. , 1993, The European respiratory journal.

[11]  Joseph Zabner,et al.  Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis , 1993, Cell.

[12]  M. Jordana,et al.  Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. , 1993, American journal of respiratory cell and molecular biology.

[13]  M. Welsh,et al.  Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. , 1993, Human gene therapy.

[14]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[15]  A. Carè,et al.  Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes , 1993 .

[16]  K. Bendtzen,et al.  Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. , 1993, Pediatric pulmonology.

[17]  Jie Yang,et al.  Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Akira,et al.  Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.

[19]  R. Crystal,et al.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. , 1992, The Journal of clinical investigation.

[20]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[21]  D. Koshland.  DNA fingerprinting and eyewitness testimony. , 1992, Science.

[22]  Matthew P. Anderson,et al.  Cystic fibrosis transmembrane conductance regulator: A chloride channel with novel regulation , 1992, Neuron.

[23]  S. Akira,et al.  NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A , 1992, Journal of virology.

[24]  M. Perricaudet,et al.  In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium , 1992, Cell.

[25]  V. Ferrans,et al.  Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Chen‐Kiang,et al.  Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Fiers.  Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.

[28]  M. Humbert,et al.  In vivo expression of IL-1 beta and IL-6 genes during viral infections in human. , 1991, European cytokine network.

[29]  M. Perricaudet,et al.  Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. , 1991, Science.

[30]  R. Chanock,et al.  A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[32]  K. Klinger,et al.  Expression and characterization of the cystic fibrosis transmembrane conductance regulator , 1990, Nature.

[33]  Matthew P. Anderson,et al.  Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells , 1990, Nature.

[34]  Mitchell L. Drumm,et al.  Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer , 1990, Cell.

[35]  L. G. Thijs,et al.  Increased plasma levels of interleukin-6 in sepsis [see comments] , 1989 .

[36]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[37]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[38]  J. Riordan,et al.  Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) : , 2008 .

[39]  E. Lennette,et al.  Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .

[40]  R. Chanock,et al.  Role of early region 3 (E3) in pathogenesis of adenovirus disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Crystal,et al.  Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. , 1989, The New England journal of medicine.

[42]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Guz,et al.  Comparison of human lung surface protein profiles from the central and peripheral airways sampled using two regional lavage techniques. , 1988, The European respiratory journal.

[44]  M. Knowles,et al.  Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. , 1981, The New England journal of medicine.

[45]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[46]  S. Greenberg,et al.  The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. , 1976, Human pathology.

[47]  J. Fox,et al.  THE VIRUS WATCH PROGRAM: A CONTINUING SURVEILLANCE OF VIRAL INFECTIONS IN METROPOLITAN NEW YORK FAMILIESI. OVERALL PLAN, METHODS OF COLLECTING AND HANDLING INFORMATION AND A SUMMARY REPORT OF SPECIMENS COLLECTED AND ILLNESSES OBSERVED , 1966 .

[48]  R. Couch,et al.  Aerosol-induced adenoviral illness resembling the naturally occurring illness in military recruits. , 1966, The American review of respiratory disease.

[49]  W. S. Jordan,et al.  Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD). , 1955, The Journal of clinical investigation.

[50]  M. Perricaudet,et al.  Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. , 1994, Human gene therapy.

[51]  M. Welsh,et al.  Safety and efficacy of repetitive adenovirus–mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats , 1994, Nature Genetics.

[52]  M. Perricaudet,et al.  Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses , 1993, Nature Genetics.

[53]  M. Perricaudet,et al.  Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. , 1993, The Journal of clinical investigation.

[54]  R. Blaese,et al.  The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990. , 1990, Human gene therapy.

[55]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[56]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .

[57]  S. Straus,et al.  Adenovirus Infections in Humans , 1984 .

[58]  L. Elveback,et al.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. , 1969, American journal of epidemiology.

[59]  R. Chanock,et al.  Newly recognized respiratory tract viruses. , 1958, Annual review of microbiology.